Literature DB >> 9165063

New insights into the mechanisms and importance of the proteasome in intracellular protein degradation.

A L Goldberg1, T N Akopian, A F Kisselev, D H Lee, M Rohrwild.   

Abstract

Recent studies of the 20S proteasome from Thermoplasma acidophilum have uncovered some fundamental new properties of its catalytic mechanism. Unlike conventional proteases, 20S and 26S proteasomes degrade protein substrates in a highly processive fashion. They cleave a protein substrate to small peptides before attacking another substrate molecule. This processive behavior is an inherent feature of the 20S particle not requiring cofactors or ATP hydrolysis. Recently, we have described a proteasome-like particle, HslVU, in Escherichia coli. HslVU is a two-component ATP-dependent protease composed of the proteasome-related peptidase HslV (beta-subunit) and the ATPase HslU. In active HslVU complex, cleavage of small peptides and proteins requires the presence of ATP. EM analysis revealed that HslV and HslU are both ring-shaped particles and that the active HslVU complex is a cylindrical four-ring structure, composed of HslV, a two-ring dodecamer, sandwiched between HslU rings. Elucidation of its mode of action may help us understand the role of ATP in function of the 26S proteasome. Several proteasome-specific inhibitors have been recently identified which block the function of proteasome in vivo. These agents have proven very useful to clarify the intracellular function of the proteasome. In mammalian cells, both the rapid degradation of short-lived regulatory proteins and of abnormal polypeptides and the slower degradation of long-lived proteins are blocked by these agents. Thus, in mammalian cells, the proteasome is the site for the degradation of most cell proteins. In contrast, in budding yeast, proteasome inhibitors block the degradation of short-lived proteins but not the breakdown of long-lived proteins, which can be blocked by inhibitors of vacuolar proteases. The inhibition of proteasome function in yeast and mammalian cells, presumably by causing an accumulation of unfolded proteins, triggers the expression of heat shock proteins and concomitantly increases cell resistance to high temperature and various toxic insults.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1997        PMID: 9165063

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  23 in total

1.  Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.

Authors:  Y Gao; S Lecker; M J Post; A J Hietaranta; J Li; R Volk; M Li; K Sato; A K Saluja; M L Steer; A L Goldberg; M Simons
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro.

Authors:  I R Garrett; D Chen; G Gutierrez; M Zhao; A Escobedo; G Rossini; S E Harris; W Gallwitz; K B Kim; S Hu; C M Crews; G R Mundy
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

Review 3.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

4.  Proteasome inhibitors prevent tracheary element differentiation in zinnia mesophyll cell cultures

Authors: 
Journal:  Plant Physiol       Date:  1998-10       Impact factor: 8.340

Review 5.  Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system.

Authors:  Q Ping Dou; Jeffrey A Zonder
Journal:  Curr Cancer Drug Targets       Date:  2014       Impact factor: 3.428

6.  Intraneuronal dopamine-quinone synthesis: a review.

Authors:  D Sulzer; L Zecca
Journal:  Neurotox Res       Date:  2000-02       Impact factor: 3.911

7.  Starvation alters the liver transcriptome of the innate immune response in Atlantic salmon (Salmo salar).

Authors:  Samuel A M Martin; Alex Douglas; Dominic F Houlihan; Christopher J Secombes
Journal:  BMC Genomics       Date:  2010-07-05       Impact factor: 3.969

8.  Inhibition of proteasome activity blocks Trypanosoma cruzi growth and metacyclogenesis.

Authors:  Josiane Cardoso; Maurilio J Soares; Rubem F S Menna-Barreto; Rozenn Le Bloas; Vanessa Sotomaior; Samuel Goldenberg; Marco A Krieger
Journal:  Parasitol Res       Date:  2008-06-26       Impact factor: 2.289

Review 9.  [Designer-drugs in tumor treatment].

Authors:  C Beck; M Kneba
Journal:  Internist (Berl)       Date:  2004-06       Impact factor: 0.743

10.  Compromised proteasome degradation elevates neuronal nitric oxide synthase levels and induces apoptotic cell death.

Authors:  Philip Y Lam; Enrique Cadenas
Journal:  Arch Biochem Biophys       Date:  2008-08-05       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.